-+ 0.00%
-+ 0.00%
-+ 0.00%

Neuronetics posts corporate presentation outlining NeuroStar TMS, clinic network growth strategy

PUBT·05/05/2026 12:28:02
Listen to the news
Neuronetics posts corporate presentation outlining NeuroStar TMS, clinic network growth strategy
  • Neuronetics reaffirmed FY 2026 revenue guidance of USD 160 million to USD 166 million, implying 7% to 11% year-on-year growth.
  • Gross margin outlook set at 47% to 49%.
  • Operating expense guidance maintained at USD 100 million to USD 105 million, including about USD 8.5 million of non-cash stock-based compensation.
  • Cash flow from operations forecast at a loss of USD 13 million to USD 17 million.
  • Q1 2026 revenue reported at USD 34.5 million, up 8% from Q1 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neuronetics Inc. published the original content used to generate this news brief on May 05, 2026, and is solely responsible for the information contained therein.